Predictors for resectability and survival in locally advanced pancreatic cancer after gemcitabine-based neoadjuvant therapy

Table 3 Univariate and Multivariate analysis of risk factors for progression-free survival following GBNAT and surgical resection

Parameter	Univariate	Multivariate
	P	OR	95% CI	P
Age	0.362	0.990	0.914-1.072	0.806
Tumor location: tail vs head or body	0.004	2.048	0.495-8.474	0.323
CA 199: pre-GBNAT <294 vs ≥294	0.003	1.776	0.357-8.850	0.483
CA 199: post-GBNAT <152 vs ≥152	0.000	26.32	3.300-200	0.002
CA 199: post-op <82 vs ≥82	0.007	2.137	0.524-8.696	0.290
CEA: post-op <6 vs ≥6	0.04	2.604	0.749-9.091	0.132
CA 125: post-GBNAT <32.8 vs ≥32.8	0.035	55.56	6.579-500	<0.001

Abbreviations: OR odds ratio, 95% CI 95% confidence interval. Bold letter means the p-values less than 0.05.

ISSN: 1471-2482